COMP <GO>
RBC vs TMO // OPERATING MARGIN
RBC Bearings Incorporated (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: RBC 7
— TMO 8
▲ OPERATING MARGIN LEADER: RBC
LAST: $462.21 (-6.76%) • MKT CAP: $15.69B
operating-margins
22.50%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RBC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RBC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.40% | 41.00% | +3.40 | RBC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.60% | 9.30% | -0.70 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 33.1x | 30.4x | +2.70 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 2.40% | -0.29 | TMO | /fcf-yield <GO> |
| Operating Margin ACTIVE | 22.50% | 17.40% | +5.10 | RBC | /operating-margins <GO> |
| Net Profit Margin | 15.40% | 15.10% | +0.30 | RBC | /net-margins <GO> |
| Revenue Growth (YoY) | 14.30% | 3.90% | +10.40 | RBC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.22 | 4.50 | +1.72 | RBC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | RBC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.70% | -0.20 | RBC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.5 | 59.1 | -22.62 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.94 | -0.07 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 45.9x | 36.3x | +9.60 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $15.69B | $262.22B | -$246.52B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RBC REV | TMO REV | RBC GROSS % | TMO GROSS % | RBC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.87B | $44.56B | 44.4% | 44.0% | $331.5M | $6.29B |
| FY 2024 | $1.64B | $42.88B | 44.4% | 44.0% | $220.0M | $7.27B |
| FY 2023 | $1.56B | $42.86B | 44.0% | 44.0% | $204.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RBC // BETA 0.87
TMO // BETA 0.94